Abstract
Prion diseases encompass a diverse group of lethal neurodegenerative disorders associated with the accumulation of misfolded conformers of the prion protein (PrP) in brain neurons. Modeling these diseases in mice and hamsters has led to major advances in our understanding of prion transmission and pathogenesis. However, laboratory rodents are also expensive, time-consuming, and limiting for systematic studies. Genetically tractable animal models, such as the nematode Caenorhabditis elegans, the fruit fly Drosophila melanogaster, and the zebrafish Danio rerio, have recently made significant contributions to PrP pathogenesis. Here, we discuss recent applications of these three nonmammalian models to various relevant areas, including PrP processing, trafficking, misfolding, neurotoxicity, as well as unraveling its elusive endogenous function. Now that these alternative models have staked a claim on PrP biology, we anticipate that they will expand their range of applications and contributions in the next few years, including the generation of nonmammalian models of prion transmissibility.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CFP:
-
Cyan fluorescent protein
- GFP:
-
Green fluorescent protein
- GSS:
-
Gerstmann–Sträussler–Scheinker
- Hsp70:
-
Heat shock protein 70
- PrP:
-
Prion protein
- PrPC :
-
Cellular PrP
- PrPSc :
-
Scrapie PrP
- SCA:
-
Spinocerebellar ataxia
- WT:
-
Wild type
References
Abid K, Morales R, Soto C (2010) Cellular factors implicated in prion replication. FEBS Lett 584:2409–2414
Aguzzi A, Baumann F, Bremer J (2008) The prion’s elusive reason for being. Annu Rev Neurosci 31:439–477
Auluck PK, Bonini NM (2002) Pharmacological prevention of Parkinson disease in Drosophila. Nat Med 8:1185–1186
Auluck PK, Chan HY, Trojanowski JQ, Lee VM, Bonini NM (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson’s disease. Science 295:865–868
Bargmann CI, Hartwieg E, Horvitz HR (1993) Odorant-selective genes and neurons mediate olfaction in C. elegans. Cell 74:515–527
Bellen HJ, Tong C, Tsuda H (2010) 100 years of Drosophila research and its impact on vertebrate neuroscience: a history lesson for the future. Nat Rev Neurosci 11:514–522
Bizat N, Peyrin JM, Haik S, Cochois V, Beaudry P et al (2010) Neuron dysfunction is induced by prion protein with an insertional mutation via a Fyn kinase and reversed by sirtuin activation in Caenorhabditis elegans. J Neurosci 30:5394–5403
Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A et al (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379:339–343
Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77:71–94
Brenner S (2009) In the beginning was the worm. Genetics 182:413–415
Chen L, Feany MB (2005) Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci 8:657–663
Chen HK, Fernandez-Funez P, Acevedo SF, Lam YC, Kaytor MD et al (2003) Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 113:457–468
Choi JK, Jeon YC, Lee DW, Oh JM, Lee HP et al (2010) A Drosophila model of GSS syndrome suggests defects in active zones are responsible for pathogenesis of GSS syndrome. Hum Mol Genet 19:4474–4489
Colby DW, Prusiner SB (2011) Prions. Cold Spring Harb Perspect Biol 3:a006833
Cotto E, Andre M, Forgue J, Fleury HJ, Babin PJ (2005) Molecular characterization, phylogenetic relationships, and developmental expression patterns of prion genes in zebrafish (Danio rerio). FEBS J 272:500–513
Deleault NR, Dolph PJ, Feany MB, Cook ME, Nishina K et al (2003) Post-transcriptional suppression of pathogenic prion protein expression in Drosophila neurons. J Neurochem 85:1614–1623
Dimitriadi M, Hart AC (2010) Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans. Neurobiol Dis 40:4–11
Feany MB, Bender WW (2000) A Drosophila model of Parkinson’s disease. Nature 404:394–398
Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM et al (2000) Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408:101–106
Fernandez-Funez P, Casas-Tinto S, Zhang Y, Gomez-Velazquez M, Morales-Garza MA et al (2009) In vivo generation of neurotoxic prion protein: role for hsp70 in accumulation of misfolded isoforms. PLoS Genet 5:e1000507
Fernandez-Funez P, Zhang Y, Casas-Tinto S, Xiao X, Zou WQ et al (2010) Sequence-dependent prion protein misfolding and neurotoxicity. J Biol Chem 285:36897–36908
Fernandez-Funez P, Zhang Y, Sanchez-Garcia J, Jensen K, Zou W et al (2011) Pulling rabbits to reveal the secrets of the prion protein. Commun Integr Biol 4(3):262–6
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE et al (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806–811
Fleisch VC, Ritzel G, Pillay L, Wang H, Waskiewicz A et al (2011) Uncovering the physiological role of Prion protein in a Zebrafish PrP mutant. Prion 5:43
Gavin BA, Dolph MJ, Deleault NR, Geoghegan JC, Khurana V et al (2006) Accelerated accumulation of misfolded prion protein and spongiform degeneration in a Drosophila model of Gerstmann-Straussler-Scheinker syndrome. J Neurosci 26:12408–12414
Graveley BR, Brooks AN, Carlson JW, Duff MO, Landolin JM et al (2011) The developmental transcriptome of Drosophila melanogaster. Nature 471:473–479
Groschup MH, Buschmann A (2008) Rodent models for prion diseases. Vet Res 39:32
Guo S (2004) Linking genes to brain, behavior and neurological diseases: what can we learn from zebrafish? Genes Brain Behav 3:63–74
Harris DA, True HL (2006) New insights into prion structure and toxicity. Neuron 50:353–357
Hill AF, Collinge J (2003) Subclinical prion infection. Trends Microbiol 11:578–584
Ingham PW (2009) The power of the zebrafish for disease analysis. Hum Mol Genet 18:R107–112
Jackson GR, Salecker I, Dong X, Yao X, Arnheim N et al (1998) Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21:633–642
Kaletta T, Hengartner MO (2006) Finding function in novel targets: C. elegans as a model organism. Nat Rev Drug Discov 5:387–398
Khan MQ, Sweeting B, Mulligan VK, Arslan PE, Cashman NR et al (2010) Prion disease susceptibility is affected by beta-structure folding propensity and local side-chain interactions in PrP. Proc Natl Acad Sci U S A 107:19808–19813
Lasmezas CI, Deslys JP, Robain O, Jaegly A, Beringue V et al (1997) Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275:402–405
Malaga-Trillo E, Sempou E (2009) PrPs: proteins with a purpose: lessons from the zebrafish. Prion 3:129–133
Malaga-Trillo E, Solis GP, Schrock Y, Geiss C, Luncz L et al (2009) Regulation of embryonic cell adhesion by the prion protein. PLoS Biol 7:e55
Malaga-Trillo E, Salta E, Figueras A, Panagiotidis C, Sklaviadis T (2010) Fish models in prion biology: underwater issues. Biochim Biophys Acta 1812:402–414
Malaga-Trillo E, Sempou E, Jechow K (2011) Using zebrafish to stufy PrP function and the molecular basis of neurodegeneration. Prion 5:3
Mange A, Milhavet O, Umlauf D, Harris D, Lehmann S (2002) PrP-dependent cell adhesion in N2a neuroblastoma cells. FEBS Lett 514:159–162
Markaki M, Tavernarakis N (2010) Modeling human diseases in Caenorhabditis elegans. Biotechnol J 5:1261–1276
Matthews KA, Kaufman TC, Gelbart WM (2005) Research resources for Drosophila: the expanding universe. Nat Rev Genet 6:179–193
Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S et al (2000) Signal transduction through prion protein. Science 289:1925–1928
Nourizadeh-Lillabadi R, Seilo Torgersen J, Vestrheim O, Konig M, Alestrom P et al (2010) Early embryonic gene expression profiling of zebrafish prion protein (Prp2) morphants. PLoS One 5:e13573
Pandey UB, Nichols CD (2011) Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol Rev 63:411–436
Park KW, Li L (2008) Cytoplasmic expression of mouse prion protein causes severe toxicity in Caenorhabditis elegans. Biochem Biophys Res Commun 372:697–702
Park Y, Kim W, Kim AY, Choi HJ, Choi JK et al (2011) Normal prion protein in Drosophila enhances the toxicity of pathogenic polyglutamine proteins and alters susceptibility to oxidative and autophagy signaling modulators. Biochem Biophys Res Commun 404:638–645
Pfeiffer BD, Ngo TT, Hibbard KL, Murphy C, Jenett A et al (2010) Refinement of tools for targeted gene expression in Drosophila. Genetics 186:735–755
Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95:13363–13383
Raeber AJ, Muramoto T, Kornberg TB, Prusiner SB (1995) Expression and targeting of Syrian hamster prion protein induced by heat shock in transgenic Drosophila melanogaster. Mech Dev 51:317–327
Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S et al (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36:585–595
Rincon-Limas DE, Casas-Tinto S, Fernandez-Funez P (2010) Exploring prion protein biology in flies: genetics and beyond. Prion 4:1–8
Rincon-Limas D, Jensen K, Fernandez Funez A (2012) Drosophila models of proteinopathies: the little fly that could. Curr Pharm Des 18:1108–1122
Rinkwitz S, Mourrain P, Becker TS (2011) Zebrafish: an integrative system for neurogenomics and neurosciences. Prog Neurobiol 93:231–243
Rivera-Milla E, Oidtmann B, Panagiotidis CH, Baier M, Sklaviadis T et al (2006) Disparate evolution of prion protein domains and the distinct origin of Doppel- and prion-related loci revealed by fish-to-mammal comparisons. FASEB J 20:317–319
Roucou X, Gains M, LeBlanc AC (2004) Neuroprotective functions of prion protein. J Neurosci Res 75:153–161
Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J (2011) Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470:540–542
Santuccione A, Sytnyk V, Leshchyns’ka I, Schachner M (2005) Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 169:341–354
Soto C, Satani N (2010) The intricate mechanisms of neurodegeneration in prion diseases. Trends Mol Med 17:14–24
Steele AD, Lindquist S, Aguzzi A (2007) The prion protein knockout mouse: a phenotype under challenge. Prion 1:83–93
Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A et al (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413:739–743
Steinhilb ML, Dias-Santagata D, Fulga TA, Felch DL, Feany MB (2007) Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. Mol Biol Cell 18:5060–5068
Sulston JE, Schierenberg E, White JG, Thomson JN (1983) The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev Biol 100:64–119
Supattapone S (2004) Prion protein conversion in vitro. J Mol Med (Berl) 82:348–356
Suzuki T, Kurokawa T, Hashimoto H, Sugiyama M (2002) cDNA sequence and tissue expression of Fugu rubripes prion protein-like: a candidate for the teleost orthologue of tetrapod PrPs. Biochem Biophys Res Commun 294:912–917
van der Kamp MW, Daggett V (2009) The consequences of pathogenic mutations to the human prion protein. Protein Eng Des Sel 22:461–468
Venken KJ, Bellen HJ (2007) Transgenesis upgrades for Drosophila melanogaster. Development 134:3571–3584
Warrick JM, Paulson HL, Gray-Board GL, Bui QT, Fischbeck KH et al (1998) Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93:939–949
Warrick JM, Chan HY, Gray-Board GL, Chai Y, Paulson HL et al (1999) Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet 23:425–428
Acknowledgments
We thank Dr. Liming Li (Northwestern University, IL) for kindly providing the worm images. This work was supported by the NIH grant DP2OD002721 to PF-F, star-up funding from the Department of Neurology (UF) to PF-F and DER-L, and funding from Deutsche Forschungsgemeinschaft (TR-SFB11), the TSE Platform of the MWK, and the FCI to EM-T.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Fernandez-Funez, P., Málaga-Trillo, E., Rincon-Limas, D.E. (2013). Alternative Models of Prion Diseases. In: Zou, WQ., Gambetti, P. (eds) Prions and Diseases. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5338-3_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5338-3_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5337-6
Online ISBN: 978-1-4614-5338-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)